Medicure (MCUJF) EBIT (2009 - 2026)

Medicure's EBIT history runs 18 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• In Q1 2026, EBIT rose 354.63% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.4 million (up 154.8% YoY), while the FY2025 annual figure was -$4.9 million, down 152.1% from the prior year.
• EBIT was $1.2 million for Q1 2026 at Medicure, up from $55215.6 in the prior quarter.
• In the past five years, EBIT ranged from a high of $4.0 million in Q4 2022 to a low of -$848142.8 in Q3 2024.
• Historically, EBIT has averaged $546434.5 across 5 years, with a median of $67879.7 in 2023.
• The sharpest annual moves came in 2025 and 2026: EBIT slumped 1718.71% in 2025, then surged 354.63% in 2026.
• A 5-year view of EBIT shows it stood at $4.0 million in 2022, then plunged by 92.69% to $291610.6 in 2023, then tumbled by 222.74% to -$357924.6 in 2024, then surged by 115.43% to $55215.6 in 2025, then surged by 2005.12% to $1.2 million in 2026.
• The last three EBIT figures came in at $1.2 million (Q1 2026), $55215.6 (Q4 2025), and $645978.5 (Q3 2025), per Business Quant data.